The children's Hospital, Denver, has participated in CCSG as a full member since 1980. During that period we have participated in all group wide clinical trials and have consistently been in the top half of institutions in terms of numbers of patients entered on CCSG protocols. Despite our relative youth within the Group, Denver is contributing to the scientific expertise of the group by providing leadership in a number of areas. We have seven memberships on five cancer strategy groups. Our faculty chairs the largest CCSG clinical study (study (CCG-105) and provides the vice- chairman for a non-Hodgkin""""""""s lymphoma protocol (CCG-502), a proposed NHL retrival protocol (CCG-554) and a proposed front line strategy groups or open or proposed clinical trial committees. In addition, we have representatives on the various discipline committees and one of our members is vice-chairman of the Surgery Committee while another is chairperson of the Nursing Committee. The principal investigator also is a member of the Group Membership Committee and Group Executive Committee. The Children's Hospital, Denver has brought to the group concepts in the areas of Pharmacology, induction therapy of acute non- lymphoblastic leukemia and the treatment of infantile monoblastic leukemia which have subsequently been developed on a group wide basis. We were invited as one of four CCSG institutions to Participate with the National Cancer in a trial of very high dose methotrexate because of our interest and recognized expertise in sophisticated supportive care. We are currently conducting a single institution study with LAK cells and lL-2 for recurrent brain tumors which has received a CCSG special study designation. Since 1980 we have had an interest in intra operative irradiation for non-resectable solid tumors and have experience with twenty- three patients so treated. This data is being evaluated by the CCSG Radiation Therapy Committee for possible group wide introduction. On a local level we have developed a data management section which consistently ranks as one of the best in CCSG and we have served as advisors and consultants to other CCSG institutions and potential members. Our institution has been audited twice, once with an NCI observer, for compliance to research requirements with no deviations found from the federal regulations.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
2U10CA028851-09
Application #
3556995
Study Section
Cancer Clinical Investigation Review Committee (CCI)
Project Start
1981-01-01
Project End
1993-11-30
Budget Start
1988-12-01
Budget End
1989-11-30
Support Year
9
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Children's Hospital of Denver
Department
Type
DUNS #
076443316
City
Aurora
State
CO
Country
United States
Zip Code
80045
Shamberger, Robert C; LaQuaglia, Michael P; Gebhardt, Mark C et al. (2003) Ewing sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapy. Ann Surg 238:563-7; discussion 567-8
Davies, Stella M; Bhatia, Smita; Ross, Julie A et al. (2002) Glutathione S-transferase genotypes, genetic susceptibility, and outcome of therapy in childhood acute lymphoblastic leukemia. Blood 100:67-71
Lange, Beverly J; Bostrom, Bruce C; Cherlow, Joel M et al. (2002) Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood 99:825-33
Ou, Shu Xiao; Han, Dehui; Severson, Richard K et al. (2002) Birth characteristics, maternal reproductive history, hormone use during pregnancy, and risk of childhood acute lymphocytic leukemia by immunophenotype (United States). Cancer Causes Control 13:15-25
Wells, R J; Arthur, D C; Srivastava, A et al. (2002) Prognostic variables in newly diagnosed children and adolescents with acute myeloid leukemia: Children's Cancer Group Study 213. Leukemia 16:601-7
Cooper, R; Khakoo, Y; Matthay, K K et al. (2001) Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children's Cancer Group. Med Pediatr Oncol 36:623-9
Sposto, R; Meadows, A T; Chilcote, R R et al. (2001) Comparison of long-term outcome of children and adolescents with disseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: A report from the Children's Cancer Group. Med Pediatr Oncol 37:432-41
Heifetz, S A; Cushing, B; Giller, R et al. (1998) Immature teratomas in children: pathologic considerations: a report from the combined Pediatric Oncology Group/Children's Cancer Group. Am J Surg Pathol 22:1115-24